144 related articles for article (PubMed ID: 6214649)
1. Cooperative role of T lymphocytes and macrophages in anti-tumor activity of mice pretreated with schizophyllan (SPG).
Suzuki M; Arika T; Amemiya K; Fujiwara M
Jpn J Exp Med; 1982 Apr; 52(2):59-65. PubMed ID: 6214649
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan.
Yamamoto T; Yamashita T; Tsubura E
Invasion Metastasis; 1981; 1(1):71-84. PubMed ID: 6234252
[TBL] [Abstract][Full Text] [Related]
3. Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
Masuda E; Maeda H
Cancer Res; 1996 Apr; 56(8):1868-73. PubMed ID: 8620506
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the induction phase of contact sensitivity by footpad transfer of regional lymph node cells. Macrophages and radioresistant T-lymphocytes induce immunity.
Asherson GL; Zembala M; Mayhew B
Immunology; 1977 Jan; 32(1):81-8. PubMed ID: 300354
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
Ye QW; Mokyr MB
Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
Ting CC; Rodrigues D
J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
[TBL] [Abstract][Full Text] [Related]
7. Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors.
Weiland E; Mussgay M
Z Immunitatsforsch Exp Klin Immunol; 1975 Nov; 150(5):414-23. PubMed ID: 181922
[TBL] [Abstract][Full Text] [Related]
8. Preparation of polyclonal antibodies to an anti-tumor (1----3)-beta-D-glucan, schizophyllan.
Tabata K; Itoh W; Hirata A; Sugawara I; Mori S
Agric Biol Chem; 1990 Aug; 54(8):1953-9. PubMed ID: 1368605
[TBL] [Abstract][Full Text] [Related]
9. Recognition of protozoan parasites by murine T lymphocytes. II. Role of the H-2 gene complex in interactions between antigen-presenting macrophages and Leishmania-immune T lymphocytes.
Louis JA; Moedder E; MacDonald HR; Engers HD
J Immunol; 1981 May; 126(5):1661-6. PubMed ID: 6452473
[TBL] [Abstract][Full Text] [Related]
10. Immune reaction induced by X-rays and pions and its stimulation by schizophyllan (SPG).
Inomata T; Goodman GB; Fryer CJ; Chaplin DJ; Palcic B; Lam GK; Nishioka A; Ogawa Y
Br J Cancer Suppl; 1996 Jul; 27():S122-5. PubMed ID: 8763863
[TBL] [Abstract][Full Text] [Related]
11. Evidence for cytostatic T cell activity in the effector mechanism against syngeneic TMT mammary tumor cells in mice.
Kurata S; Tsuchiya T; Norimura T; Yamashita U
J Immunol; 1983 Jan; 130(1):496-500. PubMed ID: 6600195
[TBL] [Abstract][Full Text] [Related]
12. Preparation and antitumor activities of beta-(1-->6) branched (1-->3)-beta-D-glucan derivatives.
Usui S; Tomono Y; Sakai M; Kiho T; Ukai S
Biol Pharm Bull; 1995 Dec; 18(12):1630-6. PubMed ID: 8787778
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
[TBL] [Abstract][Full Text] [Related]
14. Immunoregulatory and antitumor activity of schizophyllan under ultrasonic treatment.
Zhong K; Tong L; Liu L; Zhou X; Liu X; Zhang Q; Zhou S
Int J Biol Macromol; 2015 Sep; 80():302-8. PubMed ID: 26126943
[TBL] [Abstract][Full Text] [Related]
15. Enhanced tumor growth caused by anti-Th-B antiserum due to a possible activation of suppressor T-cells.
Kakimoto K; Fuji H; Grossberg AL; Pressman D
Cancer Res; 1977 Sep; 37(9):3145-50. PubMed ID: 301773
[No Abstract] [Full Text] [Related]
16. Immune response of mice to sarcoma I allograft studied by adoptive transfers of spleen, thymus, and lymph node cells to secondary recipients.
Vidrnová M; Nouza K; Panajotovová V
Neoplasma; 1985; 32(4):451-61. PubMed ID: 4047256
[TBL] [Abstract][Full Text] [Related]
17. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
Sypek JP; Panosian CB; Wyler DJ
J Immunol; 1984 Dec; 133(6):3351-7. PubMed ID: 6333458
[TBL] [Abstract][Full Text] [Related]
18. Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages.
Sugawara I; Lee KC; Wong M
Cancer Immunol Immunother; 1984; 16(3):137-44. PubMed ID: 6322974
[TBL] [Abstract][Full Text] [Related]
19. In vitro activation of human adherent cells by a glucan, Schizophyllan.
Mashiba H; Matsunaga K
Jpn J Exp Med; 1983 Aug; 53(4):195-8. PubMed ID: 6229661
[TBL] [Abstract][Full Text] [Related]
20. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.
Watson GA; Lopez DM
J Immunol; 1995 Sep; 155(6):3124-34. PubMed ID: 7673727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
